The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact and prognosis of pembrolizumab combination in neoadjuvant chemotherapy for triple-negative breast cancer: A single-center retrospective study.
 
Tomomi Fujisawa
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences
 
Takeshi Miyamoto
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Merck; Roche
 
Shoko Tokuda
Speakers' Bureau - Lilly
 
Yasuhiro Yanagita
No Relationships to Disclose
 
Kazuhiro Araki
No Relationships to Disclose
 
Misa Iijima
No Relationships to Disclose